Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2018 Earnings Call May 3, 2018 8:30 AM ET
Executives
Manisha A. Narasimhan - Regeneron Pharmaceuticals, Inc.
Leonard S. Schleifer - Regeneron Pharmaceuticals, Inc.
George Damis Yancopoulos - Regeneron Pharmaceuticals, Inc.
Marion McCourt - Regeneron Pharmaceuticals, Inc.
Robert E. Landry - Regeneron Pharmaceuticals, Inc.
Analysts
Ying Huang - Bank of America Merrill Lynch
Carter Gould - UBS Securities LLC
Terence Flynn - Goldman Sachs & Co. LLC
Geoffrey C. Porges - Leerink Partners LLC
Matthew K. Harrison - Morgan Stanley & Co. LLC
Phil Nadeau - Cowen & Co. LLC
Cory W. Kasimov - JPMorgan Securities LLC
Geoff Meacham - Barclays Capital, Inc.
Operator
Welcome to the Regeneron Pharmaceuticals First Quarter 2018 Earnings Conference Call. My name is Jason and I will be your operator. At this time all participants will be in a listen-only mode. Later, we will have a question-and-answer session. Also, please note this conference is being recorded.
And I will now turn the call over to Manisha Narasimhan, Head of Investor Relations. You may begin.

